Showing results (61-70 of 319) with videos related to
Sort By:
Pageof 32
Journal of Cutaneous Pathology|August 9, 2013
Bilateral areolar leiomyomas in a patient undergoing BRAF inhibition therapy for melanomaMichael Clarke, Bernhard Ortel, Bruce Brockstein, et al.Frontiers in Oncology|March 8, 2024
Adult-onset multifocal kaposiform hemangioendothelioma in the bone marrow, lung, liver, and brain: a case reportAlexa Bello, Mir B Alikhan, Aparna Subramaniam, et al.Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|December 21, 2011
MET and phosphorylated MET as potential biomarkers in lung cancerMaria Tretiakova, April K S Salama, Theodore Karrison, et al.Journal of Geriatric Oncology|January 30, 2014
Survival and selected outcomes of older adults with locally advanced head/neck cancer treated with chemoradiation therapyRonald J Maggiore, Emily K Curran, Mary Ellyn Witt, et al.Archives of Otolaryngology--Head & Neck Surgery|November 18, 2009
Neck response to chemoradiotherapy: complete radiographic response correlates with pathologic complete response in locoregionally advanced head and neck cancerAlexander Langerman, Colleen Plein, Everett E Vokes, et al.Clinical Lung Cancer|December 27, 2017
Feasibility of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Cytology Specimens for Next Generation Sequencing in Non-small-cell Lung CancerSean P Stoy, Jeremy P Segal, Jeffrey Mueller, et al.Oncology Reports|February 2, 2012
Everolimus exhibits efficacy as a radiosensitizer in a model of non-small cell lung cancerHelena J Mauceri, Harold G Sutton, Thomas E Darga, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 8, 2018
The Impact of Staging by Positron-Emission Tomography on Overall Survival and Progression-Free Survival in Patients With Locally Advanced NSCLCEverett E Vokes, Ramaswamy Govindan, Neill Iscoe, et al.Molecular Cancer Therapeutics|September 30, 2010
Efficacy of the multi-kinase inhibitor enzastaurin is dependent on cellular signaling contextWen-Liang Kuo, Jing Liu, Helena Mauceri, et al.Clinical Lung Cancer|February 22, 2007
A phase III study of surgical resection and paclitaxel/carboplatin chemotherapy with or without adjuvant radiation therapy for resected stage III non-small-cell lung cancer: Cancer and Leukemia Group B 9734Michael C Perry, Leslie J Kohman, James A Bonner, et al.Pageof 32